Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial.
Journal
The Lancet. Respiratory medicine
ISSN: 2213-2619
Titre abrégé: Lancet Respir Med
Pays: England
ID NLM: 101605555
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
31
10
2018
revised:
14
12
2018
accepted:
19
12
2018
pubmed:
23
3
2019
medline:
18
4
2020
entrez:
23
3
2019
Statut:
ppublish
Résumé
Non-invasive ventilation has never been compared with high-flow oxygen to determine whether it reduces the risk of severe hypoxaemia during intubation. We aimed to determine if preoxygenation with non-invasive ventilation was more efficient than high-flow oxygen in reducing the risk of severe hypoxaemia during intubation. The FLORALI-2 multicentre, open-label trial was done in 28 intensive care units in France. Adult patients undergoing tracheal intubation for acute hypoxaemic respiratory failure (a partial pressure of arterial oxygen [PaO Between April 15, 2016, and Jan 8, 2017, 2079 patients were intubated in the 28 participating units, and 322 were enrolled. We excluded five patients with no recorded data, two who withdrew consent or were under legal protection, one who was not intubated, and one who had a cardiac arrest. Of the 313 patients included in the intention-to-treat analysis, 142 were assigned to non-invasive ventilation and 171 to high-flow oxygen therapy. Severe hypoxaemia occurred in 33 (23%) of 142 patients after preoxygenation with non-invasive ventilation and 47 (27%) of 171 with high-flow oxygen (absolute difference -4·2%, 95% CI -13·7 to 5·5; p=0·39). In the 242 patients with moderate-to-severe hypoxaemia (PaO In patients with acute hypoxaemic respiratory failure, preoxygenation with non-invasive ventilation or high-flow oxygen therapy did not change the risk of severe hypoxaemia. Future research should explore the effect of preoxygenation method in patients with moderate-to-severe hypoxaemia at baseline. French Ministry of Health.
Sections du résumé
BACKGROUND
Non-invasive ventilation has never been compared with high-flow oxygen to determine whether it reduces the risk of severe hypoxaemia during intubation. We aimed to determine if preoxygenation with non-invasive ventilation was more efficient than high-flow oxygen in reducing the risk of severe hypoxaemia during intubation.
METHODS
The FLORALI-2 multicentre, open-label trial was done in 28 intensive care units in France. Adult patients undergoing tracheal intubation for acute hypoxaemic respiratory failure (a partial pressure of arterial oxygen [PaO
FINDINGS
Between April 15, 2016, and Jan 8, 2017, 2079 patients were intubated in the 28 participating units, and 322 were enrolled. We excluded five patients with no recorded data, two who withdrew consent or were under legal protection, one who was not intubated, and one who had a cardiac arrest. Of the 313 patients included in the intention-to-treat analysis, 142 were assigned to non-invasive ventilation and 171 to high-flow oxygen therapy. Severe hypoxaemia occurred in 33 (23%) of 142 patients after preoxygenation with non-invasive ventilation and 47 (27%) of 171 with high-flow oxygen (absolute difference -4·2%, 95% CI -13·7 to 5·5; p=0·39). In the 242 patients with moderate-to-severe hypoxaemia (PaO
INTERPRETATION
In patients with acute hypoxaemic respiratory failure, preoxygenation with non-invasive ventilation or high-flow oxygen therapy did not change the risk of severe hypoxaemia. Future research should explore the effect of preoxygenation method in patients with moderate-to-severe hypoxaemia at baseline.
FUNDING
French Ministry of Health.
Identifiants
pubmed: 30898520
pii: S2213-2600(19)30048-7
doi: 10.1016/S2213-2600(19)30048-7
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT02668458']
Types de publication
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
303-312Investigateurs
Delphine Chatellier
(D)
Florence Boissier
(F)
Anne Veinstein
(A)
René Robert
(R)
Céline Deletage-Métreau
(C)
Morgane Olivry
(M)
Claire Dahyot-Fizelier
(C)
Auguste Dargent
(A)
Audrey Large
(A)
Emmanuelle Begot
(E)
Claire Mancia
(C)
Maxence Decavele
(M)
Martin Dres
(M)
Samuel Lehingue
(S)
Laurent Papazian
(L)
Marine Paul
(M)
Nathalie Marin
(N)
Matthieu Le Meur
(M)
Mohammed Laissy
(M)
Anaita Rouzé
(A)
Saad Nseir
(S)
Matthieu Henry-Lagarrigue
(M)
Aihem Yehia
(A)
Frédéric Martino
(F)
Charles Cerf
(C)
Pierre Bailly
(P)
Julie Helms
(J)
Jean Baptiste Putegnat
(JB)
Armand Mekontso-Dessap
(A)
Thierry Boulain
(T)
Pierre Asfar
(P)
Séverin Cabasson
(S)
Florent Wallet
(F)
Kada Klouche
(K)
Frédéric Bellec
(F)
Delphine Chatellier
(D)
Florence Boissier
(F)
Anne Veinstein
(A)
René Robert
(R)
Céline Deletage-Métreau
(C)
Morgane Olivry
(M)
Maxence Decavele
(M)
Martin Dres
(M)
Samuel Lehingue
(S)
Laurent Papazian
(L)
Matthieu Le Meur
(M)
Mohammed Laissy
(M)
Anaita Rouzé
(A)
Saad Nseir
(S)
Matthieu Henry-Lagarrigue
(M)
Aihem Yehia
(A)
Charles Cerf
(C)
Armand Mekontso-Dessap
(A)
Thierry Boulain
(T)
Pierre Asfar
(P)
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.